TRAWS PHARMA INC (TRAW)
US68232V8019 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to TRAW. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 165.75. This target is 3426.6% above the current price.
TRAW was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about TRAW.
In the previous month the buy percentage consensus was at a similar level.
TRAW was analyzed by 8 analysts. More opinions would make the average more meaningful.